In the last years, several efforts have been made to classify colorectal cancer (CRC) into well-defined molecular subgroups, representing the intrinsic inter-patient heterogeneity, known as Consensus Molecular Subtypes (CMSs).
Mazzeschi, M., Sgarzi, M., Romaniello, D., Gelfo, V., Cavallo, C., Ambrosi, F., et al. (2022). The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancer. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 41(1), 113-131 [10.1186/s13046-022-02309-1].
The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancer
Mazzeschi, MartinaCo-primo
;Sgarzi, MichelaCo-primo
;Romaniello, Donatella;Gelfo, Valerio;Ambrosi, Francesca;Morselli, Alessandra;Miano, Carmen;Laprovitera, Noemi;Girone, Cinzia;Ferracin, Manuela;Rihawi, Karim;Ardizzoni, Andrea;Fiorentino, Michelangelo;D'Uva, Gabriele;Lauriola, Mattia
Ultimo
2022
Abstract
In the last years, several efforts have been made to classify colorectal cancer (CRC) into well-defined molecular subgroups, representing the intrinsic inter-patient heterogeneity, known as Consensus Molecular Subtypes (CMSs).File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
s13046-022-02309-1.pdf
accesso aperto
Tipo:
Versione (PDF) editoriale
Licenza:
Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione
8.96 MB
Formato
Adobe PDF
|
8.96 MB | Adobe PDF | Visualizza/Apri |
|
19451499.zip
accesso aperto
Tipo:
File Supplementare
Licenza:
Licenza per Accesso Aperto. Altra tipologia di licenza compatibile con Open Access
Dimensione
24.77 kB
Formato
Zip File
|
24.77 kB | Zip File | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
